← Evidence map

ArticleFrontiers in medicine2020

Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19.

Flavio A Cadegiani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

28 papers cite it

2020
2021
2022
2023
2024
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 32850920